Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_assertion type Assertion NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_head.
- NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_assertion wasGeneratedBy ECO_0000203 NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_provenance.
- NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_assertion wasDerivedFrom befree-2016 NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_provenance.
- NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_assertion SIO_000772 15307866 NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_provenance.
- NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_assertion evidence source_evidence_literature NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_provenance.
- NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_assertion description "[Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455691.RACh85jWYt5jSoONVFX6GgYuDhfVXAtB1kSPRma7C2VwI130_provenance.